skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
15398575
Filing Dt:
01/04/2017
Publication #:
Pub Dt:
04/27/2017
Inventors:
J. Marc Simard, Mingkui Chen
Title:
INHIBITORS OF A NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS FOR ISCHEMIC DISEASE
Assignment: 1
Reel/Frame:
040845/0697Recorded: 01/04/2017Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/17/2006
Exec Dt:
05/17/2006
Assignee:
520 WEST LOMBARD STREET
BALTIMORE, MARYLAND 21201
Correspondent:
ANNIE AYMOND-NORTON ROSE FULBRIGHT USLLP
1301 MCKINNEY STREET
HOUSTON, TX 77010
Assignment: 2
Reel/Frame:
041328/0620Recorded: 01/11/2017Pages: 2
Conveyance:
ASSIGNMENT OF A JOINT UNDIVIDED RIGHT, TITLE AND INTEREST
Assignor:
Exec Dt:
03/19/2012
Assignee:
810 VERMONT AVENUE, N.W.
OFFICE OF GENERAL COUNSEL - PSG IV (024)
WASHINGTON, DISTRICT OF COLUMBIA 20420
Correspondent:
GAIL KNOTT
620 W. LEXINGTON STREET, 4TH FLOOR
UNIVERSITY OF MARYLAND, BALTIMORE, ORD
BALTIMORE, MD 21201
Assignment: 3
Reel/Frame:
040952/0473Recorded: 01/12/2017Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/11/2017
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 08/03/2020 06:10 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT